Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of De Novo Lipogenesis in Severity of Nonalcoholic Fatty Liver Disease

NCT03683589 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT03683589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03683589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of De Novo Lipogenesis in Severity of Nonalcoholic Fatty Liver Disease
Lead sponsor
University of Missouri-Columbia
Phase
Observational
Overall status
Completed
Start date
February 1, 2019
Completion date
July 31, 2020
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bariatric surgery candidate, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, obesity, morbid